Lemonade (LMND)
(Delayed Data from NYSE)
$23.77 USD
+5.02 (26.77%)
Updated Oct 31, 2024 04:00 PM ET
After-Market: $23.77 0.00 (0.00%) 7:12 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$23.77 USD
+5.02 (26.77%)
Updated Oct 31, 2024 04:00 PM ET
After-Market: $23.77 0.00 (0.00%) 7:12 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Zacks News
Here's Why You Should Add Lemonade (LMND) to Your Kitty
by Zacks Equity Research
Lemonade (LMND) stands to gain from improvement in premium per customer, continued shift in the mix of underlying products toward higher value policies and higher instalment fees.
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Down -20.87% in 4 Weeks, Here's Why You Should You Buy the Dip in Lemonade (LMND)
by Zacks Equity Research
Lemonade (LMND) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Here's Why You Should Hold Prudential Financial (PRU) Stock
by Zacks Equity Research
Prudential Financial (PRU) benefits from higher premiums, strategic acquisitions, favorable underwriting and effective capital deployment.
Here's Why You Should Hold On to Radian Group (RDN) Stock
by Zacks Equity Research
Radian Group (RDN) is well-poised to grow, driven by higher persistency, strong-performing real estate services and a strong capital position.
Wall Street Analysts Believe Lemonade (LMND) Could Rally 40.28%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 40.3% in Lemonade (LMND). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Lemonade (LMND) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Lemonade (LMND) Q4 results reflect higher gross earned premiums, driven by an increase in in-force premium earned, which was offset by higher expense.
Lemonade (LMND) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 20.51% and 12.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Assurant (AIZ) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Assurant (AIZ) delivered earnings and revenue surprises of 24.71% and 1.25%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Lemonade (LMND): Can Its 12.8% Jump Turn into More Strength?
by Zacks Equity Research
Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Kemper (KMPR) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Kemper (KMPR) delivered earnings and revenue surprises of 18% and 1.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Should You Retain Lemonade (LMND) Stock in Your Portfolio?
by Zacks Equity Research
Lemonade (LMND) is poised to gain from growth on premium placed with third-party insurance companies , interest rates on investment balances and growth in the average policy value.
Lemonade (LMND) Q3 Earnings Lag, Revenues Top, View Revised
by Zacks Equity Research
Lemonade (LMND) Q3 results reflect higher gross earned premiums, driven by an increase in in-force premium earned but offset by higher expense.
Lemonade (LMND) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of -0.74% and 13.54%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Trean Insurance (TIG) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Trean Insurance (TIG) delivered earnings and revenue surprises of 22.22% and 11.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Enact Holdings, Inc. (ACT) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Enact Holdings, Inc. (ACT) delivered earnings and revenue surprises of 31.46% and 0.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Lemonade (LMND) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Lemonade (LMND) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Add Radian Group (RDN) to Your Portfolio
by Zacks Equity Research
Improving mortgage insurance portfolio, declining claims, the well-performing homegenius segment and solid capital position poise Radian Group (RDN) well for growth.
Lemonade (LMND) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Lemonade (LMND) closed at $21.19 in the latest trading session, marking a +0.81% move from the prior day.
Lemonade (LMND) Stock Moves -1.28%: What You Should Know
by Zacks Equity Research
Lemonade (LMND) closed at $21.66 in the latest trading session, marking a -1.28% move from the prior day.
Reasons Why Lemonade (LMND) Stock is an Attractive Pick
by Zacks Equity Research
Lemonade (LMND) is poised to gain from higher net added customers, interest rates on investment balances and growth in premiums placed with third-party insurance companies.
Lemonade (LMND) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Lemonade (LMND) Q2 results reflect improved gross earned premiums, driven by an increase in-force premium earned, which was offset by higher expense.
Lemonade (LMND) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 19.12% and 5.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Take-Two Interactive Software, Ionis Pharmaceuticals, Celsius Holdings, Grocery Outlet Holding and Lemonade
by Zacks Equity Research
Take-Two Interactive Software, Ionis Pharmaceuticals, Celsius Holdings, Grocery Outlet Holding and Lemonade are part of Zacks top Analyst Blog.
Cogent (CCOI) Q2 Earnings Beat Estimates, Revenues Lag
by Zacks Equity Research
Cogent Communications (CCOI) beats second-quarter earnings estimates due to the positive impact of foreign exchange rates